BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24178438)

  • 21. trans activation of the simian virus 40 late promoter by large T antigen requires binding sites for the cellular transcription factor TEF-1.
    Casaz P; Sundseth R; Hansen U
    J Virol; 1991 Dec; 65(12):6535-43. PubMed ID: 1658359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing alternative splice site utilization in vivo.
    Fu XY; Manley JL
    Mol Cell Biol; 1987 Feb; 7(2):738-48. PubMed ID: 3029566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of the SV40 early region without expression in permissive simian cells.
    O'Neill FJ; Xu X; Gao Y; Rosenfeld M; Jenkins F; Carney H
    Virus Res; 1994 Dec; 34(3):237-63. PubMed ID: 7856313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular targets for SV40 large T-antigen.
    Lane DP; Simanis V; Bartsch R; Yewdell J; Gannon J; Mole S
    Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):25-42. PubMed ID: 2415984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. trans-activation of cellular and viral promoters by a transforming nonkaryophilic simian virus 40 large T antigen.
    Pannuti A; Pascucci A; La Mantia G; Fisher-Fantuzzi L; Vesco C; Lania L
    J Virol; 1987 Apr; 61(4):1296-9. PubMed ID: 3029428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA.
    Erkelenz S; Poschmann G; Theiss S; Stefanski A; Hillebrand F; Otte M; Stühler K; Schaal H
    J Virol; 2013 Mar; 87(5):2721-34. PubMed ID: 23255807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of the functional activities concomitantly retained by the 115,000 Mr super T antigen, an evolutionary variant of simian virus 40 large T antigen expressed in transformed rat cells.
    May E; Lasne C; Prives C; Borde J; May P
    J Virol; 1983 Mar; 45(3):901-13. PubMed ID: 6300461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and processing of simian virus 40-specific RNA in adenovirus-infected, simian virus 40-transformed human cells.
    Flint SJ; Beltz GA; Linzer DI
    J Mol Biol; 1983 Jun; 167(2):335-59. PubMed ID: 6306259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of interference with simian virus 40 (SV40) DNA replication by trans-dominant mutants of SV40 large T antigen.
    Bentivoglio CM; Zhu J; Cole CN
    J Virol; 1992 Jul; 66(7):4209-19. PubMed ID: 1318402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New chimeric splice junction in adenovirus type 2-simian virus 40 hybrid viral mRNA.
    Khoury G; Alwine J; Goldman N; Gruss P; Jay G
    J Virol; 1980 Oct; 36(1):143-51. PubMed ID: 6255201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splicing and polyadenylylation at cryptic sites in RNA transcribed from pSV2-neo.
    Nordstrom JL; Westhafer MA
    Biochim Biophys Acta; 1986 Jun; 867(3):152-62. PubMed ID: 2872923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53.
    Borger DR; DeCaprio JA
    J Virol; 2006 May; 80(9):4292-303. PubMed ID: 16611888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the adenovirus and BK virus late promoters: effects of the BK virus enhancer and trans-acting viral early proteins.
    Grinnell BW; Berg DT; Walls J
    Mol Cell Biol; 1986 Nov; 6(11):3596-605. PubMed ID: 3025602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
    Tavis JE; Trowbridge PW; Frisque RJ
    Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic and biochemical analysis of transformation-competent, replication-defective simian virus 40 large T antigen mutants.
    Manos MM; Gluzman Y
    J Virol; 1985 Jan; 53(1):120-7. PubMed ID: 2981330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between two transcriptional control sequences required for tumor-antigen-mediated simian virus 40 late gene expression.
    Brady J; Loeken MR; Khoury G
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7299-303. PubMed ID: 2997782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of the SV40 early region in the transformed human cell line SV80.
    Flint SJ; Leong K; Beltz GA
    Virus Res; 1985 Jun; 2(4):359-73. PubMed ID: 2994314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding studies of SV40 T-antigen to SV40 binding site II.
    Gottlieb P; Nasoff MS; Fisher EF; Walsh AM; Caruthers MH
    Nucleic Acids Res; 1985 Sep; 13(18):6621-34. PubMed ID: 2997717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of sequence features involved in the recognition of tandem splice sites.
    Bortfeldt R; Schindler S; Szafranski K; Schuster S; Holste D
    BMC Genomics; 2008 Apr; 9():202. PubMed ID: 18447903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. trans Activation of the simian virus 40 late transcription unit by T-antigen.
    Brady J; Khoury G
    Mol Cell Biol; 1985 Jun; 5(6):1391-9. PubMed ID: 2993862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.